Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1245/s10434-006-9047-3.pdf
Reference27 articles.
1. Duffaud F, Blay JY. Gastrointestinal stromal tumors: biology and treatment. Oncology 2003;65:187–97
2. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438:1–12–26
3. Joensuu H, et al. Brief Report : Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal Tumor. N Engl J Med 2001;344:14
4. Verweij J, van Oosterom A, Blay JY, et al. Imatinibmesylate (STI-571 Glivec, Imatinib) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer 2003;39:2006–11
5. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinibmesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival;Journal of Gastrointestinal Surgery;2024-09
2. Pathological Complete Response After Neoadjuvant Imatinib in a Recurrent Duodenal Gastrointestinal Stromal Tumor (GIST);Cureus;2024-07-16
3. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications;Cancer Treatment and Research;2024
4. Gastrointestinal Stromal Tumor Complicated by Fistula Formation;ACG Case Reports Journal;2023-11
5. Liver resection for metastatic GIST tumor improves survival in the era of tyrosine kinase inhibitors: a systematic review and meta-analysis;Langenbeck's Archives of Surgery;2023-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3